Charles Schwab Investment Management Inc Tenaya Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 128,120 shares of TNYA stock, worth $397,172. This represents 0.0% of its overall portfolio holdings.
Number of Shares
128,120
Previous 119,532
7.18%
Holding current value
$397,172
Previous $387,000
73.13%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TNYA
# of Institutions
90Shares Held
47.2MCall Options Held
35.8KPut Options Held
1.1K-
Column Group LLC San Francisco, CA9.4MShares$29.1 Million30.64% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$20.9 Million2.84% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$14.6 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.35MShares$10.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.86MShares$8.88 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $128M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...